Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 18/03/20261 min de leitura
Determination That METHERGINE (Methylergonovine Maleate) Injection, 0.2 Milligram/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA or Agency) has determined that METHERGINE (methylergonovine maleate) injection, 0.2 milligram (mg)/milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for methylergonovine maleate injection, 0.2 mg/mL, if all other legal and regulatory requirements are met.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →